<DOC>
	<DOCNO>NCT01388829</DOCNO>
	<brief_summary>This study design compare pharmacokinetics two different lot tablet .</brief_summary>
	<brief_title>Study To Assess The Pharmacokinetics Of 2 Different Formulations Of PF-04991532</brief_title>
	<detailed_description />
	<mesh_term>Niacin</mesh_term>
	<criteria>Healthy male and/or female ( non childbearing potential ) subject age 18 55 year , inclusive . Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12 lead ECG clinical laboratory test . Women must non childbearing potential defined Lifestyle Guidelines . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) . An informed consent document sign date subject legally acceptable representative . Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) disease clinical finding Screening . Screening supine blood pressure 140 mm Hg ( systolic ) 90 mm Hg ( diastolic ) , single measurement [ confirm single repeat , necessary ] follow least 5 minute rest . Any condition possibly affect drug absorption ( eg , gastrectomy ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>formulation comparison</keyword>
</DOC>